Advertisement

Drug Investigation

, Volume 2, Issue 4, pp 268–272 | Cite as

Extensive Study of Tianeptine in General Practice

Preliminary Results
  • J. D. Guelfi
  • C. Dulcire
  • P. Le Moine
  • A. Tafani
Short Communication
  • 4 Downloads

Keywords

Drug Invest Nitrazepam Tianeptine Right Bundle Branch Block Dysthymic Disorder 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd ed, American Psychiatric Association, 1980Google Scholar
  2. Defrance R, Marey C, Kamoun A. Antidepressant and anxiolytic activities of tianeptine: an overview of clinical trials. Clinical Neuropharmacology 11 (Suppl. 2): S74–S82, 1988PubMedGoogle Scholar
  3. Delalleau B, Dulcire C, Le Moine P, Kamoun A. Analysis of the side-effects of tianeptine. Clinical Neuropharmacology 11 (Suppl. 2): S83–S89, 1988PubMedGoogle Scholar
  4. Grivois H, Niox H, Kamoun A. Étude contrôlee à double insu de l’intérêt thérapeutique de la tianeptine dans les états dépressifs des alcooliques hospitalisés pour cure de sevrage. In Perris et al. (eds) Proceedings of Third World Congress in Biological Psychiatry, Stockolm 1981, pp. 601–604, Elsevier/North-Holland, Amsterdam, 1981Google Scholar
  5. Guelfi JD, Dreyfus JF, Lacassin J, Pichot P. Etude contrôlée à double insu comparant tianeptine et sulpiride. In Perris et al. (Eds) Proceedings of Third World Congress in Biological Psychiatry, Stockholm 1981, pp.605–608, Elsevier/North-Holland, Amsterdam, 1981Google Scholar
  6. Guelfi JD, Pull CB, Guelfi C, Ruschel S, Dreyfus JF. La CHESS: utilisation dans la pathologie anxieuse et dépressive. Annales Médico-Psychologiques 141: 257–268, 1983PubMedGoogle Scholar
  7. Kato G, Weitsch AF. Neurochemical profile of tianeptine, a new antidepressant drug. Clinical Neuropharmacology 11 (Suppl 2): S43–S50, 1988PubMedGoogle Scholar
  8. Lôo H, Deniker P. Position of tianeptine among antidepressive chemotherapies. Clinical Neuropharmacology 11 (Suppl. 2): S97–S102, 1988aPubMedGoogle Scholar
  9. Lôo H, Hantzberg P, Defrance R, Kamoun A, Deniker P. Traitement par la tianeptine des syndromes dépressifs des toxicomanes sevrés: appréciation de l’efficacité et recherche de dépendance. Encéphale 13: 295–299, 1987PubMedGoogle Scholar
  10. Lôo H, Malka R, Defrance R, Barrucand D, Benard JY, et al. Tianeptine and amitriptyline: controlled double-blind trial in depressed alcoholic patients. Neuropsychobiology 19: S79–S85, 1988bCrossRefGoogle Scholar
  11. Malka R. Role of drug therapies in the treatment of alcoholism: alcohol and anxiety — alcohol and depression. Clinical Neuropharmacology 11 (Suppl. 2): S69–S73, 1988PubMedGoogle Scholar
  12. Mennini T, Garattini S. Effect of long term treatment with antidepressants on 3H-serotonin uptake and 3H-imipramine binding in rat brain. Journal of Receptor Research 7: 1–4, 1987Google Scholar
  13. Mennini T, Mocaër E, Garattini S. Tianeptine, a selective enhancer of serotonin uptake in rat brain. Naunyn Schmiedeberg’s Archives of Pharmacology 336: 478–482, 1987PubMedGoogle Scholar
  14. Mocaër E, Rettori MC, Kamoun A. Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clinical Neuropharmacology 11 (Suppl. 2): S32–S42, 1988PubMedGoogle Scholar
  15. Montgoméry SA, Åsberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134: 382–389, 1979PubMedCrossRefGoogle Scholar
  16. Olié JP, Guelfi JD, Malka R, Dulcire C, Kamoun A, et al. Traitements de longue durée par les antidépresseurs: la tianeptine: méthodologie d’une étude au long cours et résultats préliminaires. Encéphale 14: 379–384, 1988PubMedGoogle Scholar
  17. Ostaptzeff G. Etude contrôlée à double insu versus imipramine de l’efficacité de la tianeptine dans des états dépressifs non psychotiques. In Perris et al. (Eds) Proceedings of Third World Congress in Biological Psychiatry, Stockholm 1981, pp. 597–600, Elsevier/North-Holland, Amsterdam, 1981Google Scholar
  18. Renaud B, Mocaër E, Weitsch AF, Kato G, Mennini T, et al. Stimulation of serotonin uptake induced by a new antidepressant. Abstract. Pharmacopsychiatry 21: 66, 1988Google Scholar
  19. Weiss A, Gorceix A, Kindynis S, Dimitriu M. Etude contrôlée à double insu versus nomifensine de l’activité et du délai d’action d’un nouvel antidépresseur, la tianeptine. In Perris et al. (Eds) Proceedings of Third World Congress in Biological Psychiatry, Stockholm 1981, pp. 593–596, Elsevier/North-Holland, Amsterdam, 1981Google Scholar
  20. Weitsch AF, Mocaër E, Kato G. Tianeptine: a new antidepressant which increases serotonin uptake. Abstract. p.241, 15th Collegium Internationale Neuropsychopharmacologicum Congress, San Juan, 1986Google Scholar

Copyright information

© Adis International Limited 1990

Authors and Affiliations

  • J. D. Guelfi
    • 1
  • C. Dulcire
    • 2
  • P. Le Moine
    • 2
  • A. Tafani
    • 2
  1. 1.Clinique des Maladies Mentales et de l’Encéphale (Pr B. Samuel-Lajeunesse)Paris CedexFrance
  2. 2.Institut de Recherches Internationales SERVIERNeuilly-sur-SeineFrance

Personalised recommendations